Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160090593A1
SERIAL NO

14789378

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to lipid formulated double-stranded ribonucleic acid (dsRNA) targeting a transthyretin (TTR) gene, and methods of using the dsRNA to inhibit expression of TTR.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC675 WEST KENDALL STREET HENRI A TERMEER SQUARE CAMBRIDGE MA 02142-1110

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sah, Dinah Wen-Yee Boston, US 85 907

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation